A new policy analysis published in the journal Cannabis and Cannabinoid Research and by the U.S. National Library of Medicine examines what moving marijuana from Schedule I to Schedule III will actually mean under federal law—and what it would not.
New York Officials Recall Dozens of Marijuana Products After Lab Reports Unreliable Test Results
The New York State Office of Cannabis Management (OCM) has taken action against a permitted testing laboratory, after finding that results reported by the lab were unreliable.
CBD Drug Epidiolex Tops $1.1 Billion in 2025 Sales, Marking Major Milestone for Cannabis-Derived Medicine
Jazz Pharmaceuticals has announced that Epidiolex, a prescription drug containing cannabis-derived cannabidiol (CBD), brought in $1.1 billion in product sales last year, a 9% increase compared to 2024. The drug now accounts for roughly 25% of the company’s total revenue, underscoring its role as a central driver of growth.
Virginia Senate Committee Unanimously Approves Bill to Update Medical Marijuana Labels and Authorize Home Delivery
Legislation to revise Virginia’s medical marijuana labeling standards and explicitly allow home delivery received unanimous approval today by the Senate Rehabilitation and Social Services Committee. The proposal has already passed the full House.
Louisiana Bill Would Allow Terminally Ill Patients to Use Medical Marijuana in Healthcare Facilities
Legislation introduced in the Louisiana Senate would require licensed healthcare facilities to allow terminally ill patients to use medical marijuana while receiving care.
DEA Finalizes Schedule I Placement of Five Designer Benzodiazepines
The U.S. Drug Enforcement Administration has issued a final rule permanently placing clonazolam, diclazepam, etizolam, flualprazolam and flubromazolam into Schedule I of the Controlled Substances Act, solidifying federal restrictions on the five substances.
Connecticut Bill to Require Full Minimum Wage for Marijuana Workers Scheduled for March 3 Public Hearing
A Connecticut bill that would require marijuana industry employees to receive the full state minimum wage, without counting tips toward their base pay, is set to receive a public hearing on March 3 in the House Labor and Public Employees Committee.
Study: THC and CBD Combination Reduces Pain, Improves Jaw Function in Patients With Chronic TMD
New research published in Clinics (Sao Paulo) found that a combination of THC and CBD significantly reduced pain and improved jaw function in adults suffering from chronic temporomandibular disorder (TMD), a condition that often leads to persistent orofacial pain and limited movement.
Study: CBG-Dominant Cannabis Extract Reduces Fat Cell Formation and Boosts Fat Burning
A study published this month in the International Journal of Molecular Sciences reports that a cannabigerol (CBG)-dominant cannabis extract may help reduce processes linked to obesity by limiting fat cell development while increasing fat breakdown.
Alberta to Eliminate Early Payment Fee for Cannabis Producers Starting April 1
Alberta’s government has announced it will eliminate the early payment fee charged to cannabis producers, with the change taking effect April 1, 2026.
Sponsored
